Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

IsraCann Biosciences, Inc. Cannabis Stock

IsaCann Biosciences, Inc.

IsraCann Biosciences, Inc. (ISCNF) is Israel’s first pure-play cannabis company. They grow outside Tel Aviv and are trying to produce low cost cannabis for exportation into Europe. ISCNF cannabis stock is listed on the OTC markets and are headquartered in Vancouver, Canada.

Is ISCNF a strong BUY and HOLD?

IsraCann Biosciences Fundamental Analysis

Profile

HQ: Vancouver, BC, Canada
Founded: 2010
Facilities: Tel Aviv, Israel
Symbol: ISCNF (OTC), IPOT (CSE)

Focus: Strong

IsraCann is an Israeli firm focused on cultivation. They’re targeting outdoor grows to utilize the ground and sun in Israel to attempt to make low cost cannabis for export into Europe.

They are targeting production costs of only $0.40 per gram (compared to an average of $1.50 per gram in Canada). 

Size: Weak

Market Cap: US $24.27 mil
Enterprise Value: US $21.75 mil
# of employees: 3

Markets: Strong

Primary: Israel
Secondary: Europe starting with Germany
Majority Subsidiaries:   Cannisra crops Ltd, Isracann Holdings Inc, The Cranium
 

Operations: Neutral

Cultivation:
Current production: They have a JV  with 55,000 sq ft
Future capacity:  The JV can grow to 160,000 sq ft in greenhouses with lots of outdoor land available to them. Their own facility will be 230,000 sq ft and have capacity of 23,500 kg per year.

Israel was the 3rd country to develop an export framework for cannabis (behind Canada and the Netherlands). They will use this to their advantage and supply Europe with their low cost cannabis.

Israel has 46,000 medical patients with 90,000 anticipated by year’s end. 

Distribution:
Direct sales: Yes
Store networks: None

Integration/Diversification: 
Vertically integrated: Yes
Horizontally diversified: No

Financials: Weak

2020 Revenue (ttm): $310,346
Outstanding shares (diluted): 135 mil
Return on Equity: -116%

Management: Weak

President, CEO, Director: Darryl Jones
CFO: Yana Popova
COO: Matt Chatterton

Management experience includes investment advising, project management, and accounting.

Branding: Neutral

They will rely heavily on the “made in Israel” brand with a focus on quality. Both cannabis for export as well as CBD products will be explored. Low cost, lots of sun, and good soil are all benefits of growing in Israel.

Valuation: Neutral

Current share price: US $0.1748
Price to Sales: 8.83 (Tobacco industry = 5)
52 week low/high: US $0.0908- $0.549
EV/Revenue: 54.02
Price/book: 1.21

Financing: Weak

After Q3 2020 (August 31st, 2020) they had $3 million of working capital. They raised about $150k through warrants and options. The company has around $1 million in debt.

ISCNF Technical Analysis

Should I buy IsraCann Biosciences?

Follow Stephen Goldman as he evaluates IsraCann Biosciences (ISCNF) using different moving averages, the Aroon Up/Down, and the stochastic RSI.

Remember sound cannabis stock trading strategies include both Fundamental Analysis and Technical Analysis.

/
Day Range -
52 Week Range -
Market Cap
Shares Traded
Volume

Bottom Line: Is IsraCann Biosciences Cannabis Stock a Buy?

Recommendation: Neutral (for now)

IsraCann Biosciences, Inc. is a cannabis cultivator in Israel. They are striving to become a low cost cultivator, which will give them an advantage in exporting their products to Germany and eventually all of the EU.

IsraCann has been slightly delayed in planting their first crop and blame covid-19 as well as licensing. The good news is that the Israeli government has approved rules for export of cannabis. This export will occur at a fixed price of CAD $5.50 per gram. If they are indeed able to produce cannabis at $0.40 per gram there would be fantastic profit margins in supplying the EU with smokable cannabis.

Locally the Israeli market is growing too. With an estimated 200,000 patients consuming an estimated 85 tonnes per year, there should be plenty of demand locally. Although they have no revenue yet from cannabis related businesses, they do have promise. They just need to get that first crop planted.

The company reported losses of $838,792 during the three months ending August 31st, 2020. This is compared to new losses of $894,848 in 2019. They have around $3 million in working capital so they can fund most of 2021 now. Without significant revenue after that from cultivating they will need to raise funds.

We generally like this company, although the management team is slightly inexperienced. If they can have a few successful harvests and export to Germany, there will be revenue to drive stock prices higher. This is at least 5-6 months away however. For the short term, this is rated Neutral but watch it long term for this to switch to Strong.

If you are looking for more productive cannabis companies, check out our Featured Companies Page for many other winners in the cannabis and hemp industry.

Symbol Name Last Price Change % Change
Algorithmic Stock Trading Hemp Stocks

Cannabis Investment Strategies For High Profits

Investing in cannabis stocks sounds like both an exciting and daunting prospect at the same time. But if you can live with the adrenaline rush, there couldn't be a better way to keep your money growing. While these stocks have a risk factor, so does any other kind of...

Want to Invest in a Massachusetts Cannabis Cultivation Facility?

Want to Invest in a Massachusetts Cannabis Cultivation Facility? -- ORANGE, Mass., Sept. 21, 2021 /PRNewswire/ -- An exciting crowd funding cannabis cultivation project is scheduled to start this week for Grow Space Orange, the Massachusetts company that develops...

5 Most-Preferred Ways to Consume CBD Effectively

Unarguably, the CBD market comes under one of the fastest-growing consumer markets in the USA and worldwide. Talking about the most significant reason behind this raised demand is the legalization of cannabis in almost every state after the 2018 farm bill. Besides,...

CENTR Brands Corp. Announces Q1’22 473% Record Sales Increase

CENTR Brands Corp. Announces Q1'22 473% Record Sales Increase -- Vancouver, British Columbia--(Newsfile Corp. - September 20, 2021) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company") announced today record gross sales for Q1'22 (ended August...

Why Now Is The Best Time To Invest In Cannabis Stocks

A diverse investment strategy can make you a winner in the stock market. The landscape offers endless opportunities to multiply your money, but everything boils down to picking the right stocks at the right time. But you need not pick blue-chip ones to make big...

How To Invest In Cannabis Stocks – For Beginners

With continuous decriminalization in the states, the cannabis industry has shown signs of a tremendous economic boom. In 2019, the industry was valued at $1,788 million USD and it was expected to grow at a surprising 17% CAGR till 2026. More so, Covid-19 has reshaped...